Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Leiden University Medical Center, Leiden

Universitair Ziekenhuis Gasthuisberg, Leuven

NYU, New York

Columbia University, New York

Charite Berline, Berlin

CHU Rangueil, Toulouse

CHU de Bordeaux. Hôpital Pellegrin, Bordeaux

University of Alabama Hospital (at Birmingham), Birmingham

Vanderbilt University, Nashville

CHU de Grenoble - Hôpital Michalon, Grenoble

Mayo Clinic (Rochester), Rochester

Centre Regional Hospitalier Universitaire de Lille, Lille

University of Illinois Chicago, Chicago

Hospital Edouard Herriot Lyon, Lyon

Hopital saint Louis Paris, Paris

Necker Hospital, Paris

Houston Methodist, Houston

Mayo Clinic Arizona, Phoenix

California Pacific, San Francisco

Yale New Haven Hospital, New Haven

Brigham & Women's, Boston

St. Barnabas Medical Center, Livingston

University of Wisconsin, Madison

Hospital Universitari Vall d'Hebron, Barcelona

Hospital Clinic de Barcelona, Barcelona

Guy's Hospital, London